| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $438K | +333.6% | +223.4% |
| Cost of Revenue | $538K | +974.3% | +381.4% |
| Gross Profit | -$100K | -296.7% | -524.0% |
| R&D Expense | $810K | +224.1% | -13.9% |
| SG&A Expense | $1.5M | -6.6% | +24.0% |
| Operating Income | -$2.3M | -44.9% | -9.8% |
| Pre-tax Income | -$2.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.1M | +109.2% | +24.7% |
| Short-term Investments | $0 | — | -100.0% |
| Accounts Receivable | $674K | +128.5% | +108.2% |
| Inventory | $527K | -34.1% | +16.6% |
| Current Assets | $6.3M | +64.1% | -8.4% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.2M | — | — |
| Capital Expenditures | $60K | — | — |
| Investing Cash Flow | $1.6M | — | — |
| Financing Cash Flow | $6.0M | — | — |
| Free Cash Flow | -$5.2M | — | — |
| -33.7% |
| -7.2% |
| Income Tax | $250 | -83.3% | +0.0% |
| Net Income | -$2.3M | -33.6% | -7.2% |
| EPS (Basic) | -$0.66 | +47.2% | +29.0% |
| EPS (Diluted) | -$0.66 | +47.2% | +29.0% |
| $6.7M |
| +60.0% |
| -9.9% |
| Current Liabilities | $2.2M | +30.0% | +67.7% |
| Long-term Debt | $150K | +0.0% | +0.0% |
| Total Liabilities | $2.3M | +27.6% | +60.7% |
| Stockholders' Equity | $4.4M | +82.4% | -26.6% |